Icelandic gene pioneer deCode returns as private firm

26.01.10 Reykjavik – Iceland's deCode Genetics has reimmerged as a private biotechnology company following its purchase from its former parent company by Saga Investments LLC, a consortium that includes Polaris Ventures and ARCH Venture... more

FP6 networks die away

04.12.09 Luxembourg – Billions of euros spent on so-called Networks of Excellence (NoEs) during the EU’s 6th Framework Programme appear to have brought little return. A new study by the European Court of Auditors has revealed that the... more

Calling top researchers

01.12.09 Brussels – The European Research Council (ERC) has launched a call to attract top international researchers to EU labs (more...). The proposal deadline for the life sciences arm of the Advanced Investigators Grants, which foresee... more

Second IMI call

15.11.09 Brussels – The Innovative Medicines Initiative (IMI) has published its second call for funding. “By accelerating and optimising R&D processes, we are trying to remove bottlenecks in the drug development process,” explained Arthur... more

Atlas Venture closes new funds

01.02.09 The international early-stage Venture Capital specialist Atlas Venture has closed its eighth fund at US$283m. Atlas Venture VIII will fund early-stage technology and life sciences start-ups in the US and Europe. Investors in the... more